Dassault Systèmes Takes Its Life Sciences Ambition to the Next Level with a Unified AI Platform Connecting Science, Medicine and Patients

VELIZY-VILLACOUBLAY, France–(BUSINESS WIRE)– #3DEXPERIENCE–Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced it has completed the acquisition of ArisGlobal and is now uniting its Life Sciences and Healthcare capabilities into a unified AI platform that connects science, medicine and patients. The milestones advance its ambition to improve people’s lives by empowering faster drug discovery, better therapies and smarter decisions. Dr. Ashwini Zenooz has been appointed Executive Vice Pre

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.